Mostrar el registro sencillo del ítem
Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited
dc.contributor.author | Keshavarzi Z. | |
dc.contributor.author | Shakeri F. | |
dc.contributor.author | Barreto G.E. | |
dc.contributor.author | Bibak B. | |
dc.contributor.author | Sathyapalan T. | |
dc.contributor.author | Sahebkar A. | |
dc.date.accessioned | 2020-09-02T22:21:07Z | |
dc.date.available | 2020-09-02T22:21:07Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1002/biof.1516 | |
dc.identifier.citation | 45, 4, 517-535 | |
dc.identifier.issn | 09516433 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5001 | |
dc.description | Traumatic brain injury (TBI) is the most prevalent health problem affecting all age groups, and leads to many secondary problems in other organs especially kidneys, gastrointestinal tract, and heart function. In this review, the search terms were TBI, fluid percussion injury, cold injury, weight drop impact acceleration injury, lateral fluid percussion, cortical impact injury, and blast injury. Studies with Actaea racemosa, Artemisia annua, Aframomum melegueta, Carthamus tinctorius, Cinnamomum zeylanicum, Crocus sativus, Cnidium monnieri, Curcuma longa, Gastrodia elata, Malva sylvestris, Da Chuanxiong Formula, Erigeron breviscapus, Panax ginseng, Salvia tomentosa, Satureja khuzistanica, Nigella sativa, Drynaria fortune, Dracaena cochinchinensis, Polygonum cuspidatum, Rosmarinus officinalis, Rheum tanguticum, Centella asiatica, and Curcuma zedoaria show a significant decrease in neuronal injury by different mechanisms such as increasing superoxide dismutase and catalase activities, suppressing nuclear factor kappa B (NF-κB), interleukin 1 (IL-1), glial fibrillary acidic protein, and IL-6 expression. The aim of this study was to evaluate the neuroprotective effects of medicinal plants in central nervous system pathologies by reviewing the available literature. © 2019 International Union of Biochemistry and Molecular Biology | |
dc.language.iso | en | |
dc.publisher | Blackwell Publishing Inc. | |
dc.subject | brain | |
dc.subject | medicinal plants | |
dc.subject | signaling mechanisms | |
dc.subject | TBI | |
dc.subject | trauma | |
dc.subject | Actaea racemosa extract | |
dc.subject | Aframomum melegueta extract | |
dc.subject | Artemisia annua extract | |
dc.subject | catalase | |
dc.subject | Centella asiatica extract | |
dc.subject | Cinnamomum zeylanicum extract | |
dc.subject | Cnidium monnieri extract | |
dc.subject | Crocus sativus extract | |
dc.subject | Curcuma longa extract | |
dc.subject | Curcuma zedoaria extract | |
dc.subject | da chuanxiong | |
dc.subject | Dracaena cochinchinensis extract | |
dc.subject | Drynaria fortune extract | |
dc.subject | Erigeron breviscapus extract | |
dc.subject | Gastrodia elata extract | |
dc.subject | ginseng extract | |
dc.subject | glial fibrillary acidic protein | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | interleukin 1 | |
dc.subject | interleukin 6 | |
dc.subject | Malva sylvestris extract | |
dc.subject | Nigella sativa extract | |
dc.subject | plant medicinal product | |
dc.subject | Polygonum cuspidatum extract | |
dc.subject | Rheum tanguticum extract | |
dc.subject | Rosmarinus officinalis extract | |
dc.subject | safflower extract | |
dc.subject | Salvia tomentosa extract | |
dc.subject | Satureja khuzistanica extract | |
dc.subject | superoxide dismutase | |
dc.subject | unclassified drug | |
dc.subject | catalase | |
dc.subject | glial fibrillary acidic protein | |
dc.subject | glial fibrillary astrocytic protein, mouse | |
dc.subject | immunoglobulin enhancer binding protein | |
dc.subject | interleukin 1 | |
dc.subject | interleukin 6 | |
dc.subject | interleukin-6, mouse | |
dc.subject | neuroprotective agent | |
dc.subject | superoxide dismutase | |
dc.subject | Actaea racemosa | |
dc.subject | Aframomum melegueta | |
dc.subject | Artemisia annua | |
dc.subject | black cumin | |
dc.subject | blast injury | |
dc.subject | Centella asiatica | |
dc.subject | Cinnamomum zeylanicum | |
dc.subject | Cnidium monnieri | |
dc.subject | cold injury | |
dc.subject | Crocus sativus | |
dc.subject | Curcuma longa | |
dc.subject | Curcuma zedoaria | |
dc.subject | cytokine release | |
dc.subject | Dracaena cochinchinensis | |
dc.subject | drug formulary | |
dc.subject | drug mechanism | |
dc.subject | Drynaria fortune | |
dc.subject | Erigeron breviscapus | |
dc.subject | Gastrodia elata | |
dc.subject | ginseng | |
dc.subject | Malva sylvestris | |
dc.subject | medicinal plant | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | Polygonum cuspidatum | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | Rheum tanguticum | |
dc.subject | rosemary | |
dc.subject | safflower | |
dc.subject | Salvia tomentosa | |
dc.subject | Satureja khuzistanica | |
dc.subject | traumatic brain injury | |
dc.subject | animal | |
dc.subject | blast injury | |
dc.subject | brain cortex | |
dc.subject | chemistry | |
dc.subject | cold injury | |
dc.subject | disease model | |
dc.subject | drug effect | |
dc.subject | gene expression regulation | |
dc.subject | genetics | |
dc.subject | human | |
dc.subject | injury | |
dc.subject | isolation and purification | |
dc.subject | medicinal plant | |
dc.subject | metabolism | |
dc.subject | mouse | |
dc.subject | pathology | |
dc.subject | rat | |
dc.subject | traumatic brain injury | |
dc.subject | Animals | |
dc.subject | Blast Injuries | |
dc.subject | Brain Injuries, Traumatic | |
dc.subject | Catalase | |
dc.subject | Cerebral Cortex | |
dc.subject | Cold Injury | |
dc.subject | Disease Models, Animal | |
dc.subject | Gene Expression Regulation | |
dc.subject | Glial Fibrillary Acidic Protein | |
dc.subject | Humans | |
dc.subject | Interleukin-1 | |
dc.subject | Interleukin-6 | |
dc.subject | Mice | |
dc.subject | Neuroprotective Agents | |
dc.subject | NF-kappa B | |
dc.subject | Plants, Medicinal | |
dc.subject | Rats | |
dc.subject | Superoxide Dismutase | |
dc.title | Medicinal plants in traumatic brain injury: Neuroprotective mechanisms revisited | |
dc.type | Review |